AIM: To determine whether the promoter polymorphism -203A>C of cholesterol-7α-hydroxylase encoding gene (CYP7A1) affects diurnal variation in CYP7A1 enzyme activity. METHODS: The study included 16 healthy male volunteers - 8 homozygous for -203A and 8 homozygous for the -203C allele of CYP7A1. Three 15-hour examinations (from 7am to 10pm) were carried out for each of the participants: after one-day treatment with cholestyramine; after one-day treatment with chenodeoxycholic acid (CDCA); and a control examination without any treatment. The plasma concentration of 7α-hydroxy-4-cholesten-3-one (C4), a marker of CYP7A1 activity, was determined in all the experiments at 90-min intervals. RESULTS: CYP7A1 activity was up-regulated after treatment with cholestyramine and suppressed after treatment with CDCA. There were no differences between -203A and -203C allele carriers in the response of enzyme activity to both drugs. In the control experiment, -203A allele carriers displayed diurnal variation in enzyme activity, whereas CYP7A1 activity did not change in -203C allele carriers. These results were confirmed by modeling the dynamics of C4 using polynomial regression. CONCLUSION: The promoter polymorphism of the CYP7A1 gene has a pronounced impact on diurnal variation in CYP7A1 activity.

Tereza Blahova Laboratory for Atherosclerosis Research Institute for Clinical and Experimental Medicine Vídenska 1958 9 140 21 Prague 4 Czech Republic

Zobrazit více v PubMed

Chiang JY. Bile acids: regulation of synthesis. J Lipid Res. 2009;50:1955–66. doi: 10.1194/jlr.R900010-JLR200. PubMed DOI PMC

Chiang JY. Bile acid metabolism and signaling. Compr Physiol. 2013;3:1191–212. PubMed PMC

Ferrell JM, Chiang JY. Circadian rhythms in liver metabolism and disease. Acta Pharm Sin B. 2015;5:113–22. doi: 10.1016/j.apsb.2015.01.003. PubMed DOI PMC

Galman C, Angelin B, Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology. 2005;129:1445–53. doi: 10.1053/j.gastro.2005.09.009. PubMed DOI

Axelson M, Bjorkhem I, Reihner E, Einarsson K. The plasma level of 7 alpha-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7 alpha-hydroxylase in man. FEBS Lett. 1991;284:216–8. doi: 10.1016/0014-5793(91)80688-Y. PubMed DOI

Sauter G, Berr F, Beuers U, Fischer S, Paumgartner G. Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Hepatology. 1996;24:123–6. PubMed

Kovar J, Lenicek M, Zimolova M, Vitek L, Jirsa M, Pitha J. Regulation of diurnal variation of cholesterol 7alpha-hydroxylase (CYP7A1) activity in healthy subjects. Physiol Res. 2010;59:233–8. PubMed

Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC. Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest. 1998;101:1283–91. doi: 10.1172/JCI1343. PubMed DOI PMC

Couture P, Otvos JD, Cupples LA, Wilson PW, Schaefer EJ, Ordovas JM. Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J Lipid Res. 1999;40:1883–9. PubMed

Hubacek JA, Pitha J, Skodova Z, Poledne R, Lanska V, Waterworth DM, et al. Polymorphisms in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study. Clin Biochem. 2003;36:263–7. doi: 10.1016/S0009-9120(03)00025-0. PubMed DOI

Hofman MK, Weggemans RM, Zock PL, Schouten EG, Katan MB, Princen HM. CYP7A1 A-278C polymorphism affects the response of plasma lipids after dietary cholesterol or cafestol interventions in humans. J Nutr. 2004;134:2200–4. PubMed

Kovar J, Suchanek P, Hubacek JA, Poledne R. The A-204C polymorphism in the cholesterol 7alpha-hydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a high-fat diet. Physiol Res. 2004;53:565–8. PubMed

Kajinami K, Brousseau ME, Ordovas JM, Schaefer EJ. Interactions between common genetic polymorphisms in ABCG5/G8 and CYP7A1 on LDL cholesterol-lowering response to atorvastatin. Atherosclerosis. 2004;175:287–93. doi: 10.1016/j.atherosclerosis.2004.03.015. PubMed DOI

Lenicek M, Komarek V, Zimolova M, Kovar J, Jirsa M, Lukas M, et al. CYP7A1 promoter polymorphism -203A>C affects bile salt synthesis rate in patients after ileal resection. J Lipid Res. 2008;49:2664–7. doi: 10.1194/jlr.M800364-JLR200. PubMed DOI

Lenicek M, Juklova M, Zelenka J, Kovar J, Lukas M, Bortlik M, et al. Improved HPLC Analysis of Serum 7{alpha}-Hydroxycholest-4-en-3-one, a Marker of Bile Acid Malabsorption. Clin Chem. 2008;54:1087–8. doi: 10.1373/clinchem.2007.100107. PubMed DOI

Lundasen T, Galman C. Angelin, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med. 2006;260:530–6. doi: 10.1111/j.1365-2796.2006.01731.x. PubMed DOI

De Castro-Oros I, Pampin S, Cofan M, Mozas P, Pinto X, Salas-Salvado J, et al. Promoter variant -204A > C of the cholesterol 7alpha-hydroxylase gene: association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells. Clin Nutr. 2011;30:239–46. doi: 10.1016/j.clnu.2010.07.020. PubMed DOI

Ferrell JM, Chiang JY. Short-term circadian disruption impairs bile acid and lipid homeostasis in mice. Cell Mol Gastroenterol Hepatol. 2015;1:664–77. doi: 10.1016/j.jcmgh.2015.08.003. PubMed DOI PMC

Kim DH, Rhee JC, Yeo S, Shen R, Lee SK, Lee JW, et al. Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice. Hepatology. 2015;61:1012–23. doi: 10.1002/hep.27578. PubMed DOI PMC

Noshiro M, Kawamoto T, Furukawa M, Fujimoto K, Yoshida Y, Sasabe E, et al. Rhythmic expression of DEC1 and DEC2 in peripheral tissues: DEC2 is a potent suppressor for hepatic cytochrome P450s opposing DBP. Genes Cells. 2004;9:317–29. doi: 10.1111/j.1356-9597.2004.00722.x. PubMed DOI

Duez H, van der Veen JN, Duhem C, Pourcet B, Touvier T, Fontaine C, et al. Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha. Gastroenterology. 2008;135:689–98. doi: 10.1053/j.gastro.2008.05.035. PubMed DOI

Ma K, Xiao R, Tseng HT, Shan L, Fu L, Moore DD. Circadian dysregulation disrupts bile acid homeostasis. PLoS ONE. 2009;4:e6843. doi: 10.1371/journal.pone.0006843. PubMed DOI PMC

Nakamoto K, Wang S, Jenison RD, Guo GL, Klaassen CD, Wan YJ, et al. Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene. BMC Genet. 2006;7:29. doi: 10.1186/1471-2156-7-29. PubMed DOI PMC